FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: February 28, 2011
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
Paolini John F.
  2. Issuer Name and Ticker or Trading Symbol
Kiniksa Pharmaceuticals International, plc [KNSA] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
CHIEF MEDICAL OFFICER
(Last)
(First)
(Middle)
23 OLD BOND STREET, THIRD FLOOR		 3. Date of Earliest Transaction (Month/Day/Year)
09/01/2024
(Street)

LONDON, X0 W1S 4PZ		 4. If Amendment, Date Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4) 		7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Class A Ordinary Share 09/01/2024   M   4,121 A (1) 53,142 D  
Class A Ordinary Share 09/01/2024   F   1,994 D $ 26.74 51,148 D  
Class A Ordinary Share 09/02/2024   M   1,725 A (1) 52,873 D  
Class A Ordinary Share 09/02/2024   F   835 D $ 26.74 52,038 D  
Class A Ordinary Share 09/03/2024   M(2)   60,217 A $ 1.86 112,255 D  
Class A Ordinary Share 09/03/2024   M(2)   475 A $ 3.8 112,730 D  
Class A Ordinary Share 09/03/2024   S(2)   59,214 D $ 26.09 (3) 53,516 D  
Class A Ordinary Share 09/03/2024   S(2)   1,478 D $ 27.13 (4) 52,038 D  

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5) 		6. Date Exercisable and Expiration Date
(Month/Day/Year) 		7. Title and Amount of Underlying Securities
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4) 		10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4) 		11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Share Unit (1) 09/01/2024   A   7,000     (5)   (5) Class A Ordinary Share 7,000 $ 0 7,000 D  
Share Option $ 26.74 09/01/2024   A   36,350     (6) 08/31/2034 Class A Ordinary Share 36,350 $ 0 36,350 D  
Restricted Share Unit (1) 09/01/2024   M     2,497   (7)   (7) Class A Ordinary Share 2,497 $ 0 4,995 D  
Restricted Share Unit (1) 09/01/2024   M     1,624   (8)   (8) Class A Ordinary Share 1,624 $ 0 4,872 D  
Restricted Share Unit (1) 09/02/2024   M     1,725   (9)   (9) Class A Ordinary Share 1,725 $ 0 1,725 D  
Share Option $ 1.86 09/03/2024   M(2)     60,217   (10) 09/13/2026 Class A Ordinary Share 60,217 $ 0 0 D  
Share Option $ 3.8 09/03/2024   M(2)     475   (10) 06/28/2027 Class A Ordinary Share 475 $ 0 44,549 D  

Reporting Owners

Reporting Owner Name / Address Relationships
 Director  10% Owner  Officer  Other
Paolini John F.
23 OLD BOND STREET, THIRD FLOOR
LONDON, X0 W1S 4PZ		       CHIEF MEDICAL OFFICER  

Signatures

 /s/ Madelyn Zeylikman, Attorney-in-Fact   09/04/2024
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer.
(2) This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on May 16, 2024.
(3) This transaction was executed in multiple trades through a broker-dealer at prices ranging from $25.88 to $26.82. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
(4) This transaction was executed in multiple trades through a broker-dealer at prices ranging from $26.995 to $27.18. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full informationregarding the number of Shares sold at each price.
(5) The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the grant date September 1, 2024.
(6) The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is September 1, 2024.
(7) The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2022.
(8) The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2023.
(9) The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the vesting commencement date September 2, 2021.
(10) The option is fully vested and exercisable.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.